JPMorgan Chase & Co. Sells 1,744 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

JPMorgan Chase & Co. lowered its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.5% in the third quarter, Holdings Channel.com reports. The institutional investor owned 69,017 shares of the company’s stock after selling 1,744 shares during the period. JPMorgan Chase & Co.’s holdings in U.S. Physical Therapy were worth $5,841,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy during the second quarter worth $28,000. Quest Partners LLC grew its position in U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares during the last quarter. Quarry LP increased its holdings in U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares in the last quarter. KBC Group NV raised its position in U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of U.S. Physical Therapy by 74.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 958 shares of the company’s stock valued at $89,000 after purchasing an additional 409 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on USPH. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Barrington Research reaffirmed an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $114.00.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 2,000 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. This trade represents a 10.68 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the transaction, the chief operating officer now directly owns 7,106 shares in the company, valued at approximately $684,236.74. This represents a 19.52 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,412 shares of company stock worth $706,605. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $88.72 on Friday. The firm has a market capitalization of $1.34 billion, a PE ratio of 94.38, a price-to-earnings-growth ratio of 3.58 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The firm has a fifty day simple moving average of $92.80 and a two-hundred day simple moving average of $88.96.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.98%. U.S. Physical Therapy’s payout ratio is 187.23%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.